At the time of writing, Inhibrx Biosciences Inc [INBX] stock is trading at $58.85, up 2.72%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INBX shares have gain 53.98% over the last week, with a monthly amount glided 80.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Inhibrx Biosciences Inc fluctuated between $10.81 and $60.20. Inhibrx Biosciences Inc [NASDAQ: INBX] shares were valued at $58.85 at the most recent close of the market.
Analyzing the INBX fundamentals
According to Inhibrx Biosciences Inc [NASDAQ:INBX], the company’s sales were 1.40M for trailing twelve months, which represents an 1200.00% jump. Gross Profit Margin for this corporation currently stands at -0.99% with Operating Profit Margin at -119.3%, Pretax Profit Margin comes in at -116.92%, and Net Profit Margin reading is -116.92%. To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -1.38 and Total Capital is -0.96. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 54.42 points at the first support level, and at 50.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 62.24, and for the 2nd resistance point, it is at 65.64.
Ratios To Look Out For
It is important to note that Inhibrx Biosciences Inc [NASDAQ:INBX] has a current ratio of 4.98. As well, the Quick Ratio is 4.98, while the Cash Ratio is 4.79. Considering the valuation of this stock, the price to sales ratio is 608.91, the price to book ratio is 12.43.
Transactions by insiders
Recent insider trading involved VIKING GLOBAL INVESTORS LP, 10% Owner, that happened on Oct 07 ’25 when 0.35 million shares were sold. Director, Kayyem Jon Faiz completed a deal on Nov 19 ’24 to buy 69686.0 shares. Meanwhile, Director Kayyem Jon Faiz bought 37500.0 shares on Nov 20 ’24.
